Vaccine-Preventable Diseases

Top Story

FDA approves Flucelvax Quadrivalent

May 24, 2016

The FDA recently approved Flucelvax Quadrivalent — the first seasonal influenza vaccine to be cell-derived and to protect against the four major strains of influenza A and B — for patients aged 4 years and older, according to its manufacturer.

“Flucelvax Quadrivalent will provide health care providers and their patients with an important option to further broaden their influenza coverage,” Gordon Naylor, president of Seqirus, said in a press release. “We are pleased to offer Flucelvax Quadrivalent … to our valued customers during the 2016-2017 flu season.”

HIV Vaccine Awareness Day: Research continues for effective preventive, therapeutic vaccines

May 18, 2016
National HIV Vaccine Awareness Day is observed annually on May 18 to mark the progress made in developing an effective HIV vaccine, to acknowledge those who have…
In the Journals

Uniformity in male HPV vaccinations encouraged in Canada

May 18, 2016
A recent Canadian analysis published in CMAJ reported that male vaccination programs are necessary in order to ensure equality in protection from HPV-associated diseases…

Ongoing varicella outbreak affects 75 children in New York

May 17, 2016
The New York City Department of Health and Mental Hygiene recently issued an advisory to physicians concerning an ongoing investigation into 75 cases of varicella in the…
CME

Identifying and Addressing Vaccine Hesitancy

Pediatric Annals, April 2015, Volume 44 Issue 4
In the 20th century, the introduction of multiple vaccines significantly reduced childhood morbidity, mortality, and…
More »
CE CME CNE

Immunization Updates 2015: Pediatrics & Adolescents

This activity is supported by an educational grant from Merck & Co. Inc.

Despite the proven remarkable effectiveness of vaccines and the striking global impact of immunization campaigns in…
More »
Featured
PAS 2016

PAS 2016

Video
Meeting News Coverage

Internet misinformation, dated beliefs continue to fuel vaccine hesitancy

November 24, 2015
More »
In the Journals

Dengue vaccine shows full protection in human challenge model

March 16, 2016
A dengue vaccine currently in phase 3 development was 100% effective at preventing the disease, according to the results of a small clinical trial in…

EditorialPublication Exclusive

Hardly harmless: The dangerous tradition of ‘pox parties’

Infectious Diseases in Children, March 2016
Walter A. Orenstein, MD; Julie R. Garon, MPH
Varicella, more commonly known as chickenpox, was previously thought of as a harmless rite of passage for all children. Before the development of an…

In the Journals

Norovirus-driven gastroenteritis in Quebec more common after start of rotavirus vaccine

March 3, 2016
After Quebec initiated a rotavirus vaccination program in 2011, norovirus became more prevalent than rotavirus in cases of pediatric gastroenteritis…

In the Journals

Discount voucher intervention fails to increase Tdap cocooning

March 2, 2016
Retail pharmacy vouchers, distributed with a video public service announcement, did not successfully promote Tdap vaccination among adult parents of…

In the Journals

Increased vaccines decrease overall childhood mortality in Netherlands

March 1, 2016
Increasing vaccination coverage led to a decrease in overall childhood mortality, according to a historical analysis published in Lancet Infectious

In the Journals

Gardasil significantly reduces prevalence of HPV strains among females

February 29, 2016
Implementation of Gardasil quadrivalent HPV vaccine in 2006 significantly reduced the prevalence of HPV-6, -11, -16 and -18 strains among girls and…

Breaking News

ACIP: Flu vaccine 59% effective to date

February 25, 2016
The CDC’s Advisory Committee for Immunization Practices continued to recommend that all people aged 6 months and older be vaccinated annually…

In the JournalsPerspective

Timely DTaP vaccination could reduce infant pertussis, hospitalizations

February 22, 2016
Timely DTaP vaccination among newborn infants could reduce cases of pertussis-related hospitalization and death, according to recent research in the…

In the Journals

No increased risk for death at 30 days after adolescent vaccination

February 17, 2016
The risk for death was not increased during the 30 days following vaccination of adolescents, with no deaths found to be causally associated with…

In the Journals

MOC program improves HPV vaccination rates

February 16, 2016
An American Board of Pediatrics maintenance of certification program led to improved HPV vaccination rates by participating pediatricians, according…

More Headlines »
morganatic-roan
morganatic-roan